Literature DB >> 9640707

Teleradiology: a review.

C Ruggiero1.   

Abstract

Teleradiology, like telemedicine generally, has arisen because of the shift to digital communication and the demand for equal access to medical care. Unlike much of telemedicine, teleradiology can be shown to be cost-effective in many situations, particularly if the alternatives are to transport the X-ray film to a radiologist or to use the services of a visiting radiologist ('circuit riding'). A teleradiology system consists of an image-acquisition section and an image-display section, connected by a communications network. Considerable technical and clinical standardization work has been carried out (e.g. by the American College of Radiology) and commercial teleradiology systems are now available from a number of manufacturers. Up to 1994, more than 7000 teleradiology systems had been sold by the two largest manufactures. Technology trends suggest that it will soon be common for clinicians to view digital radiographs from outside radiology departments and probably from outside a hospital environment as well.

Mesh:

Year:  1998        PMID: 9640707     DOI: 10.1258/1357633981931245

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

1.  Biomedical imaging informatics in the era of precision medicine: progress, challenges, and opportunities.

Authors:  William Hsu; Mia K Markey; May D Wang
Journal:  J Am Med Inform Assoc       Date:  2013 Nov-Dec       Impact factor: 4.497

2.  Image quality in real-time teleultrasound of infant hip exam over low-bandwidth internet links: a transatlantic feasibility study.

Authors:  Dobrivoje Martinov; Veljko Popov; Zoran Ignjatov; Robert D Harris
Journal:  J Digit Imaging       Date:  2013-04       Impact factor: 4.056

3.  Assessment of telemedicine in surgical education and patient care.

Authors:  N Demartines; D Mutter; M Vix; J Leroy; D Glatz; F Rösel; F Harder; J Marescaux
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.